Serum Adiponectin Is Associated with Worsened Overall Survival in a Prospective Cohort of Hepatocellular Carcinoma Patients | Zendy

Abby B. Siegel | Zendy; Abhishek Goyal | Zendy; Marcela Salomao | Zendy; Shuang Wang | Zendy; Valerie Lee | Zendy; Christine Hsu | Zendy; Rosa Rodríguez | Zendy; Dawn L. Hershman | Zendy; Robert S. Brown | Zendy; Alfred I. Neugut | Zendy; Jean C. Emond | Zendy; Tomoaki Kato | Zendy; Benjamin Samstein | Zendy; David Faleck | Zendy; Raffi Karagozian | Zendy

Open Access

Serum Adiponectin Is Associated with Worsened Overall Survival in a Prospective Cohort of Hepatocellular Carcinoma Patients

Author(s) -

Abby B. Siegel,

Abhishek Goyal,

Marcela Salomao,

Shuang Wang,

Valerie Lee,

Christine Hsu,

Rosa Rodríguez,

Dawn L. Hershman,

Robert S. Brown,

Alfred I. Neugut,

Jean C. Emond,

Tomoaki Kato,

Benjamin Samstein,

David Faleck,

Raffi Karagozian

Publication year - 2014

Publication title -

oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.987

H-Index - 98

eISSN - 1423-0232

pISSN - 0030-2414

DOI - 10.1159/000367971

Subject(s) - adiponectin , medicine , hepatocellular carcinoma , hazard ratio , adipokine , gastroenterology , prospective cohort study , cirrhosis , cancer , diabetes mellitus , endocrinology , confidence interval , insulin , insulin resistance

Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. The rise in metabolic syndrome has contributed to this trend. Adipokines, such as adiponectin, are associated with prognosis in several cancers, but have not been well studied in HCC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research